From FDA approvals to studies, here are six key updates in total disc replacements since July 1.
1. Centinel Spine earned FDA approval for the Prodisc C Vivo, Prodisc C Nova and Prodisc C SK. The products received the FDA's pre-market application approval for single-level applications.
2. Spineway acquired France-based Spine Innovations, a company specializing in cervical and lumbar disc prostheses. Spine Innovations is known for its viscoelastic lumbar prosthesis, LP-ESP, which was first implanted in 2004.
3. The artificial cervical intervertebral disc market is expected to reach a $4.37 billion valuation by 2028, according to a July 25 report.
4. AxioMed completed the final steps toward FDA approval for its lumbar viscoelastic disc replacement device. The third and final module needed to get FDA approval to market was submitted.
5. A study published in The Spine Journal concluded that patient improvement in neck pain was greater than improvement in arm pain following cervical disc replacements. It based its findings on patient reported outcomes, and created a neck disability index, a visual analog scale for neck and arm pain, a short form physical health score and a short form mental health score to rate each patient on, to determine overall success.
6. Jason Tinley, MD, completed the first commercial case with Centinel Spine's Prodisc C Vivo in the U.S.